Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software

from Vital Signs with Jacob Effron and Nikhil Krishnan · host Thomas Swalla, Nikhil Krishnan, Jacob Effron

Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. 0:00 intro0:36 getting into healthcare5:20 what R&D looks like today8:03 what does Dotmatics do?13:06 differences in software requirements across biotechs20:15 bundling vs. “best-of-breed”23:46 do life sciences need their own data tools?26:44 incorporating AI into Dotmatics tools34:38 AI replacing scientists37:39 how Dotmatics tools can serve companies outside of life sciences39:50 acquisition strategy44:43 spaces for innovation in R&D

Episode metadata supplied by the publisher feed · Published Jun 27, 2023

Embed this episode

Attribution link and audio player

What this episode covers

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software

0:00 48:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Vital Signs with Jacob Effron and Nikhil Krishnan?

This episode is 48 minutes long.

When was this Vital Signs with Jacob Effron and Nikhil Krishnan episode published?

This episode was published on June 27, 2023.

Can I download this Vital Signs with Jacob Effron and Nikhil Krishnan episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!